FACTANKER

US-Listed Medicinal Chemicals & Botanical Products — EBITDA Margin Percentiles, FY 2025

Population: 20 US-listed companies (SIC 2833), fiscal year 2025; fiscal year ends 2025-06-30 to 2026-03-31.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile-21.5%
25th percentile-4.9%
Median1.9%
75th percentile12.7%
90th percentile20.5%
Mean-0.2%
Minimum-51.7%
Maximum22.1%
Methodology & sources
EBITDA margin = (operating income + depreciation & amortization) / revenue, all values as filed; computed in SQL per company, then percentiles. Fiscal year 2025 = fiscal years ending 2025-06-01 to 2026-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-03.

Evidence samples

Latest EBITDA Margin percentiles (live) · All Medicinal Chemicals & Botanical Products benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-2833/ebitda-margin/2025